Schneyer A L, Sluss P M, Bosukonda D, Reichert L E
Endocrinology. 1986 Oct;119(4):1446-53. doi: 10.1210/endo-119-4-1446.
A method is described for electrophoretic purification of [125I]human (h) FSH after radioiodination that improves radioligand binding to FSH membrane receptors. Lactoperoxidase-iodinated hFSH was separated from reaction products by electrophoresis on 7.5% polyacrylamide tube gels (PAGE). Material eluted from 3-mm gel slices was analyzed for incorporation of 125I and binding to antibody (RIA) or receptor (RRA), and by sodium dodecyl sulfate-PAGE for protein composition. Sodium dodecyl sulfate-PAGE analysis of individual PAGE fractions demonstrated that iodinated proteins, both higher and lower in apparent mol wt than intact FSH, were separated by PAGE, but not by gel filtration chromatography (Sephadex G-25). PAGE purification of radioligand resulted in significantly greater (compared to gel filtration) RRA sensitivity and specificity. Maximum binding of PAGE-purified [125I]hFSH to excess calf tests membrane receptors was 45%, with a specific activity of approximately 26 microCi/micrograms, as determined by the method of self-displacement. Maximum binding to excess hFSH antisera (NIH anti-hFSH 4) was 80-85%. This allowed a useful final dilution of 1:120,000, thereby facilitating development of a sensitive and specific RIA with this antiserum. These data indicate that PAGE separation of intact [125I]hFSH from other iodinated proteins results in improved radioligand binding, assay sensitivity, and assay specificity. In addition, PAGE-purified lactoperoxidase-iodinated hFSH is suitable for use in both RIA and RRA.
本文描述了一种在碘化后对[125I]人促卵泡激素(hFSH)进行电泳纯化的方法,该方法可提高放射性配体与FSH膜受体的结合。通过在7.5%聚丙烯酰胺管凝胶(PAGE)上进行电泳,将乳过氧化物酶碘化的hFSH与反应产物分离。分析从3毫米凝胶切片洗脱的物质中125I的掺入情况、与抗体(放射免疫分析,RIA)或受体(放射受体分析,RRA)的结合情况,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析蛋白质组成。对各个PAGE组分进行的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析表明,表观分子量高于或低于完整FSH的碘化蛋白可通过PAGE分离,但不能通过凝胶过滤色谱法(葡聚糖凝胶G-25)分离。放射性配体的PAGE纯化导致RRA的灵敏度和特异性显著提高(与凝胶过滤相比)。通过自身置换法测定,PAGE纯化的[125I]hFSH与过量小牛睾丸膜受体的最大结合率为45%,比活约为26微居里/微克。与过量hFSH抗血清(NIH抗-hFSH 4)的最大结合率为80 - 85%。这使得最终有用稀释度达到1:120,000,从而便于用这种抗血清开发灵敏且特异的RIA。这些数据表明,从其他碘化蛋白中通过PAGE分离完整的[125I]hFSH可提高放射性配体结合、检测灵敏度和检测特异性。此外,PAGE纯化的乳过氧化物酶碘化hFSH适用于RIA和RRA。